Mario Naranjo-Tovar (@marionaranjomd) 's Twitter Profile
Mario Naranjo-Tovar

@marionaranjomd

Pulmonary & Critical Care Attending @TempleLung via @JHUPCCMFellows | MHS @JohnsHopkinsSPH | IM via @JeffHealthEH | PH & RV enthusiast #ThePeoplesVentricle

ID: 3166703573

calendar_today14-04-2015 18:38:53

47 Tweet

240 Followers

268 Following

Mario Naranjo-Tovar (@marionaranjomd) 's Twitter Profile Photo

Our recent work addressing causes and outcomes of ICU hospitalizations in PAH patients. RHF, most common cause for admission and in-hospital mortality. CTD-PAH has lower 1-year survival. Good news, mortality trend is improving Johns Hopkins University PCCM Fellowship Hopkins Pulmonary and Critical Care Medicine ATS PC Assembly ERS publications

ERS publications (@erspublications) 's Twitter Profile Photo

Pulmonary vascular disease is relevant to many practising respiratory clinicians: ∼1% of the world's population is estimated to have PH, and it is an important consequence of many other respiratory diseases (e.g. COPD, ILD, sleep breathing disorders) bit.ly/3hLqUx1

Pulmonary vascular disease is relevant to many practising respiratory clinicians: ∼1% of the world's population is estimated to have PH, and it is an important consequence of many other respiratory diseases (e.g. COPD, ILD, sleep breathing disorders) bit.ly/3hLqUx1
The Pulmonary Hypertension Association (@phassociation) 's Twitter Profile Photo

Today is #WorldPHDay2023! Now through May 31, join us in raising #pulmonaryhypertension awareness; advocating for access to #PH diagnosis, treatment and care; and celebrating the lives of people with PH. Learn how you can get involved. ow.ly/TiLo50NRUVe.

Today is #WorldPHDay2023! Now through May 31, join us in raising #pulmonaryhypertension awareness; advocating for access to #PH diagnosis, treatment and care; and celebrating the lives of people with PH. Learn how you can get involved.  ow.ly/TiLo50NRUVe.
Mario Naranjo-Tovar (@marionaranjomd) 's Twitter Profile Photo

Excited to join the amazing faculty, fellows, and staff at Temple University - Department of Thoracic Medicine & Surgery. Looking forward to working, collaborating, and learning from you all Temple Lung Center Temple Health TemplePCCM

Excited to join the amazing faculty, fellows, and staff at Temple University - 
 Department of Thoracic Medicine &amp; Surgery. Looking forward to working, collaborating, and learning from you all <a href="/TempleLung/">Temple Lung Center</a> <a href="/TempleHealth/">Temple Health</a> <a href="/TemplePCCM/">TemplePCCM</a>
Temple Health (@templehealth) 's Twitter Profile Photo

Temple University Hospital once again leads the nation, performing more lung transplants than any other center in 2022. With the dedication of our transplant team, we're able to perform transplants for some of the most complex cases, with leading outcomes: bit.ly/45HWXlg

Temple University Hospital once again leads the nation, performing more lung transplants than any other center in 2022. With the dedication of our transplant team, we're able to perform transplants for some of the most complex cases, with leading outcomes: bit.ly/45HWXlg
Temple Lung Center (@templelung) 's Twitter Profile Photo

On #WorldLungDay we reflect on the global impact of chronic respiratory diseases, and unite to promote better lung health for all. We remain committed to expanding access to preventative services and treatment–and advancing lung health through research, advocacy & education.

On #WorldLungDay we reflect on the global impact of chronic respiratory diseases, and unite to promote better lung health for all. We remain committed to expanding access to preventative services and treatment–and advancing lung health through research, advocacy &amp; education.
Temple Lung Center (@templelung) 's Twitter Profile Photo

Temple Lung Center continues to lead in lung care & transplantation. In 2024, we surpassed national benchmarks with a 90%+ survival rate in lung transplants and offer 50+ clinical trials for breakthrough therapies. Learn more: bit.ly/3YfBrTy

Temple Lung Center continues to lead in lung care &amp; transplantation. In 2024, we surpassed national benchmarks with a 90%+ survival rate in lung transplants and offer 50+ clinical trials for breakthrough therapies. Learn more: bit.ly/3YfBrTy